Ascendis Pharma Investigational Site

Saint Paul, Minnesota 55102

1 studies enrolling now · 7 studies all time

What they study most

Achondroplasia, Endocrine System Diseases, Growth Hormone Deficiency, Pediatric, Hormone Deficiency, Hormones, Idiopathic Short Stature, Pituitary Diseases, Short Stature Homeobox Gene Mutation, Small for Gestational Age at Delivery, Turner Syndrome, hGH (Human Growth Hormone)

Studies at this site

• Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders — Recruiting now
• A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Children With Achondroplasia — Completed
• A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial — Completed
• A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD) — Completed
• A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of TransCon CNP Administered Once Weekly in Prepubertal Children With Achondroplasia — Completed
• A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome — Running, not enrolling
• A Multi-center, Longitudinal, Observational Study of Children With Achondroplasia — Completed